Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$249.89
-2.0%
$251.33
$196.00
$278.56
$2.74T1.4656.85 million shs45.22 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$77.98
+7.2%
$70.83
$54.11
$89.98
$28.06B1.454.35 million shs6.64 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amazon.com, Inc. stock logo
AMZN
Amazon.com
+3.02%+4.65%+3.63%+2.11%+12.64%
DexCom, Inc. stock logo
DXCM
DexCom
-1.88%-1.80%-2.01%+18.78%-14.21%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$249.89
-2.0%
$251.33
$196.00
$278.56
$2.74T1.4656.85 million shs45.22 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$77.98
+7.2%
$70.83
$54.11
$89.98
$28.06B1.454.35 million shs6.64 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amazon.com, Inc. stock logo
AMZN
Amazon.com
+3.02%+4.65%+3.63%+2.11%+12.64%
DexCom, Inc. stock logo
DXCM
DexCom
-1.88%-1.80%-2.01%+18.78%-14.21%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amazon.com, Inc. stock logo
AMZN
Amazon.com
2.95
Moderate Buy$312.7625.16% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.89
Moderate Buy$85.369.46% Upside

Current Analyst Ratings Breakdown

Latest DXCM and AMZN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Set Price TargetOverweight$330.00 ➝ $335.00
7/16/2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Initiated CoverageOutperform$293.00
7/16/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetBuy$80.00 ➝ $87.00
7/15/2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Reiterated RatingMarket Outperform
7/15/2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Reiterated RatingMarket Outperform$315.00
7/15/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetOutperform$85.00 ➝ $90.00
7/9/2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Reiterated RatingBuy$335.00
7/8/2026
DexCom, Inc. stock logo
DXCM
DexCom
UpgradeHold (C-)Hold (C)
7/8/2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Reiterated RatingBuy$350.00 ➝ $340.00
7/2/2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Reiterated RatingOverweight$312.00 ➝ $313.00
6/26/2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Reiterated RatingBuy
(Data available from 7/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$716.92B3.75$13.10 per share19.08$38.29 per share6.53
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B6.45$2.97 per share26.27$7.04 per share11.08
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$77.67B$8.3629.8924.771.9012.22%19.92%9.86%7/30/2026 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.3433.3225.571.2019.31%33.33%13.19%7/30/2026 (Confirmed)

Latest DXCM and AMZN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$1.82N/AN/AN/A$196.18 billionN/A
7/30/2026Q2 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.61N/AN/AN/A$1.29 billionN/A
4/30/2026Q1 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.47$0.56+$0.09$0.51$1.17 billion$1.19 billion
4/29/2026Q1 2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$1.63$2.78+$1.15$2.78$177.28 billion$181.52 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Amazon.com, Inc. stock logo
AMZN
Amazon.com
N/AN/AN/AN/AN/A
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amazon.com, Inc. stock logo
AMZN
Amazon.com
0.27
1.18
1.01
DexCom, Inc. stock logo
DXCM
DexCom
0.42
1.95
1.64

Institutional Ownership

CompanyInstitutional Ownership
Amazon.com, Inc. stock logo
AMZN
Amazon.com
72.20%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%

Insider Ownership

CompanyInsider Ownership
Amazon.com, Inc. stock logo
AMZN
Amazon.com
8.90%
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amazon.com, Inc. stock logo
AMZN
Amazon.com
1,576,00010.76 billion9.80 billionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000385.87 million384.79 millionOptionable

Recent News About These Companies

Dexcom (DXCM) Receives a Buy from BTIG
1 Mid-Cap Stock to Target This Week and 2 We Find Risky
Dexcom (DXCM) Receives a Buy from Citi

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amazon.com stock logo

Amazon.com NASDAQ:AMZN

$249.89 -5.07 (-1.99%)
Closing price 04:00 PM Eastern
Extended Trading
$251.02 +1.14 (+0.45%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.

DexCom stock logo

DexCom NASDAQ:DXCM

$77.98 +5.25 (+7.22%)
Closing price 04:00 PM Eastern
Extended Trading
$77.62 -0.36 (-0.46%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.